68 studies found for:    Open Studies | "Clostridium difficile"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Condition: Clostridium Difficile Infection
Interventions: Drug: CB-183,315;   Drug: oral vancomycin
2 Recruiting Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: C. difficile Toxoid Vaccine;   Biological: Placebo: 0.9% normal saline
3 Not yet recruiting The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers
Conditions: Clostridium Difficile;   Colitis
Intervention:
4 Recruiting Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Drug: Vancomycin;   Dietary Supplement: fruit juice/placebo
5 Not yet recruiting Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis
Conditions: Clostridium Difficile;   Clostridium Difficile Infection
Interventions: Biological: FMT;   Drug: Vancomycin
6 Recruiting IMT for Primary Clostridium Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: Intestinal microbiota therapy;   Drug: Metronidazole
7 Recruiting Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection
Condition: Clostridium Difficile Infection
Intervention:
8 Not yet recruiting Transplantation of Fecal Microbiota for Clostridium Difficile Infection
Condition: Clostridium Difficile Infection
Intervention: Procedure: Fecal Microbiota transplantation.
9 Not yet recruiting Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis
Condition: Clostridium Difficile
Intervention: Drug: fecal microbiota transplantation
10 Recruiting Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile
Conditions: Antibiotic-associated Diarrhea;   Clostridium Difficile
Intervention: Dietary Supplement: Lactobacillus reuteri
11 Recruiting Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?
Condition: Clostridium Difficile Infection
Interventions: Other: Environmental sampling;   Other: Skin swab sampling;   Other: Fecal sampling
12 Recruiting Probiotics for Reduction of Infections With Clostridium Difficile in Critically Ill Patients
Conditions: Clostridium Difficile Colonisation;   Impact of Enteral Probiotics on Certain Lab Parameters
Interventions: Dietary Supplement: L. plantarum 299 and L. plantarum 299v (+maltodextrin);   Other: Maltodextrin
13 Recruiting Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
Condition: Clostridium Difficile Diarrhea
Interventions: Drug: Metronidazole;   Drug: Placebo
14 Recruiting A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Condition: Clostridium Difficile-associated Diarrhea (CDAD)
Interventions: Drug: Fidaxomicin;   Drug: Vancomycin
15 Recruiting A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population
Condition: Clostridium Difficile
Interventions: Drug: Fidaxomicin;   Drug: Vancomycin
16 Recruiting A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Condition: Clostridium Difficile Infection
Interventions: Drug: SMT19969;   Drug: Vancomycin
17 Recruiting Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
Condition: Clostridium Difficile Infection
Interventions: Drug: Fidaxomicin;   Drug: Treatment for CDI other than fidaxomicin Type
18 Not yet recruiting Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
Conditions: Inflammatory Bowel Disease (IBD);   Clostridium Difficile Infection (CDI)
Intervention: Drug: fidaxomicin
19 Recruiting Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
Condition: Infections, Clostridium Difficile
Interventions: Procedure: Blood sampling;   Other: Stool sample collection
20 Recruiting Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
Condition: Recurrent Clostridium Difficile Infection
Interventions: Biological: RBX2660 (microbiota suspension);   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years